AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
BA   151.39 (+3.80%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Supernus PharmaceuticalsEsperion TherapeuticsAimmune TherapeuticsNextCureIntra-Cellular Therapies
SymbolNASDAQ:SUPNNASDAQ:ESPRNASDAQ:AIMTNASDAQ:NXTCNASDAQ:ITCI
Price Information
Current Price$23.85$42.06$16.45$29.90$20.86
52 Week RangeHoldBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.82.02.41.61.5
Analysis Score3.24.34.34.43.5
Community Score3.12.83.02.82.6
Dividend Score0.00.00.00.00.0
Ownership Score1.03.04.01.01.0
Earnings & Valuation Score1.90.00.60.00.6
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$30.50$81.42$40.09$64.67$37.13
% Upside from Price Target27.88% upside93.57% upside143.71% upside116.28% upside77.97% upside
Trade Information
Market Cap$1.26 billion$1.13 billion$1.08 billion$858.82 million$1.39 billion
Beta1.592.160.98N/A1.86
Average Volume566,294708,240993,759224,351862,509
Sales & Book Value
Annual Revenue$392.76 million$148.36 millionN/A$6.35 million$60,000.00
Price / Sales3.197.83N/A129.5823,102.45
Cashflow$2.47 per shareN/AN/AN/AN/A
Price / Cash9.65N/AN/AN/AN/A
Book Value$11.35 per share$0.73 per share$1.66 per share$14.13 per share$3.52 per share
Price / Book2.1057.62N/A2.125.93
Profitability
Net Income$113.06 million$-97,170,000.00$-248,500,000.00$-33,740,000.00$-147,720,000.00
EPS$2.10($3.59)($3.97)($2.15)($2.68)
Trailing P/E Ratio10.99N/AN/AN/AN/A
Forward P/E Ratio14.37N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins28.90%-5,492.02%N/A-65.22%N/A
Return on Equity (ROE)20.31%-627.38%-155.39%-7.12%-57.81%
Return on Assets (ROA)10.28%-109.71%-92.41%-6.39%-48.47%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.62%0.06%0.59%0.01%0.05%
Current Ratio3.31%2.35%8.10%40.07%14.83%
Quick Ratio3.16%2.33%8.01%40.07%14.79%
Ownership Information
Institutional Ownership Percentage92.86%N/A71.85%73.98%72.25%
Insider Ownership Percentage7.86%7.70%13.75%N/A18.20%
Miscellaneous
Employees44876228N/A73
Shares Outstanding52.54 million27.62 million65.25 million27.52 million66.45 million
Next Earnings Date8/4/2020 (Estimated)8/13/2020 (Estimated)8/13/2020 (Estimated)8/10/2020 (Estimated)8/5/2020 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.